Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Mineralys Therapeutics Inc (MLYS)

Mineralys Therapeutics Inc (MLYS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 655,367
  • Shares Outstanding, K 49,649
  • Annual Sales, $ 0 K
  • Annual Income, $ -71,900 K
  • 60-Month Beta 1.97
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.06
Trade MLYS with:

Options Overview Details

View History
  • Implied Volatility 44.96% ( -46.21%)
  • Historical Volatility 53.68%
  • IV Percentile 20%
  • IV Rank 19.26%
  • IV High 217.21% on 09/27/23
  • IV Low 3.88% on 09/05/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 23
  • Volume Avg (30-Day) 8
  • Put/Call OI Ratio 0.11
  • Today's Open Interest 334
  • Open Int (30-Day) 281

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.73
  • Number of Estimates 4
  • High Estimate -0.68
  • Low Estimate -0.84
  • Prior Year -0.31
  • Growth Rate Est. (year over year) -135.48%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.04 +23.82%
on 06/26/24
15.12 -9.59%
on 07/16/24
+1.63 (+13.54%)
since 06/21/24
3-Month
10.70 +27.76%
on 04/25/24
15.12 -9.59%
on 07/16/24
+2.53 (+22.71%)
since 04/22/24
52-Week
5.85 +133.68%
on 11/22/23
16.91 -19.14%
on 02/27/24
-1.44 (-9.53%)
since 07/21/23

Most Recent Stories

More News
There's a Lot to Love About Mineralys' Valentine's Day IPO

MLYS added 20% more shares to IPO funding, which goes live on 2/14. The bump secured liquidity to stabilize development, improving market cap to $683 million

MLYS : 13.67 (+3.56%)
AZN : 79.16 (+0.57%)
CINC : 29.06 (-0.48%)
GPCR : 36.59 (-2.27%)

Business Summary

Mineralys Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. Mineralys Therapeutics Inc. is based in RADNOR, Pa.

See More

Key Turning Points

3rd Resistance Point 14.55
2nd Resistance Point 14.15
1st Resistance Point 13.91
Last Price 13.67
1st Support Level 13.27
2nd Support Level 12.87
3rd Support Level 12.63

See More

52-Week High 16.91
Last Price 13.67
Fibonacci 61.8% 12.68
Fibonacci 50% 11.38
Fibonacci 38.2% 10.07
52-Week Low 5.85

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar